Developmental Therapeutics Committee
The Development Therapeutics Committee is in a unique position to facilitate the creation of new types of cancer treatment trials that personalize therapy using predictive biomarkers and drug targets. Its role in the Group is to:
- Educate members about new treatments, drug targets, and biomarker technologies
- Provide a platform for disseminating scientific concepts that arise within the 12 cancer-type-oriented committees and working groups in the Therapeutic Studies Program
- Conduct correlative studies that explore variability in patients and tumors, with a treatment focus rather than a disease focus
The original concept for the landmark NCI-MATCH precision medicine cancer trial originated in this committee as part of a collaboration with researchers at the National Cancer Institute and throughout the National Clinical Trials Network (NCTN).
